VIM and breast carcinoma: To avoid the potential effects of endogenous vimentin on the assembly of mCherry-vimentin in the NIH3T3 cells, the organization of mCherry-vimentin and the mutants was also visualized in human breast cancer MCF7 cells that do not express endogenous vimentin (Fig. 5b).